TD Waterhouse Canada’s Whitehawk Therapeutics WHWK Stock Holding History
Bought
Maintained
Sold
Other funds holding WHWK
YIH
ECM
PFSRSONJ
BCWM
SCM
SS
TD Waterhouse Canada's WHWK Position: Q2 2026 in Review
TD Waterhouse Canada held its Whitehawk Therapeutics (WHWK) position steady in Q2 2026 at 232 shares worth $993. The position accounts for ﹤0.01% of the portfolio, ranked #2198.
TD Waterhouse Canada first reported a position in WHWK in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.68K in Q4 2021. 8 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.
- TD Waterhouse Canada held 232 shares of Whitehawk Therapeutics worth $993 as of Q2 2026.
- TD Waterhouse Canada left its Whitehawk Therapeutics share count unchanged in Q2 2026.
- Whitehawk Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2198 holding.
- TD Waterhouse Canada first reported a position in Whitehawk Therapeutics in Q4 2021 and has held it in 18 quarters since.
- TD Waterhouse Canada's Whitehawk Therapeutics position peaked at $5.68K in Q4 2021.
- 8 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.
Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.